The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the earlier announcements in relation to the Proposals.

We refer to the earlier announcements dated 7 June 2023, 1 August 2023, 8 September 2023, 15 January 2024, 16 January 2024, 17 January 2024 and 31 January 2024 in relation to the Proposals.

On behalf of the Board, UOBKH wishes to announce that as at the close of acceptance, excess application and payment for the Rights Issue with Warrants as at 5.00 p.m. on Thursday, 22 February 2024, the total acceptances and excess applications for the Rights Issue with Warrants were 239,553,486 Rights Shares, which represents an over-subscription of 11.27% over the total number of 215,281,192 Rights Shares available for subscription under the Rights Issue with Warrants, the details of which are set out below:-

Successful applicants of the Rights Shares will be given Warrants B on the basis of 1 Warrant B for every 2 Rights Shares successfully subscribed for.

It is the intention of the Board to allot the excess Rights Shares with Warrants B, if any, in a fair and equitable basis. The Board has applied the following basis and priority in allocating the excess Rights Shares with Warrants B, in accordance with the Abridged Prospectus dated 31 January 2024:-

i.          Firstly, to minimise the incidence of odd lots;

ii.         Secondly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants B, calculated based on their respective shareholdings in the Company as at the Entitlement Date;

iii.         Thirdly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants B, calculated based on the quantum of their respective Excess Applications; and

iv.        Finally, on a pro-rata basis and in board lots, to the renouncee(s) and/ or transferee(s) (if applicable) who have applied for Excess Rights Shares with Warrants B, calculated based on the quantum of their respective Excess Rights Shares with Warrants B applied for.

In the event there is any remaining balance of the Excess Rights Shares with Warrants B after carrying out steps (i) to (iv) set out above, steps (ii) to (iv) will be repeated again in the same sequence to allocate the remaining balance of the Excess Rights Shares with Warrants B until such balance is fully allocated.

Nevertheless, the Board reserves the right to allocate any Excess Rights Shares with Warrants B applied for under Part I(B) of the RSF in such manner as the Board deems fit, expedient and in the best interests of the Company, subject always to such allocation being made on a fair and equitable basis, and that the intention of the Board as set out in step (i) to (iv) above is achieved. The Board also reserves the right at its absolute discretion not to accept any Excess Application, in full or in part, without assigning any reason thereto.

The Rights Shares and Warrants B are expected to be listed on the ACE Market of Bursa Securities on 7 March 2024.

This announcement is dated 29 February 2024.